Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Alvotech
Bear Case (25th pct.)
-57.6% vs price
Base Case (Median)
-52.9% vs price
Bull Case (75th pct.)
-30.4% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $2.80 | -52.9% | High (40%) |
| PE Comparable | $2.24 | -62.3% | Medium (25%) |
| EV/EBITDA | $5.48 | -7.8% | Medium (20%) |
Based on 3 out of 7 methods, ALVO appears overvalued at the current price of $5.95. The base case fair value of $2.80 implies 52.9% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.